- Email: [email protected]
Most Popular Evidence-Base Oncology Articles in 2004
CANCER TREATMENT REVIEWS (2005) 31, I
www.elsevierhealth.com/journals/ctrv
ANNOUNCEMENT
Most Popular Evidence-based Oncology Articles in 2004! The articles below were the most electronically downloaded Evidence-based Oncology articles last year in this journal. To find out what your peers are reading, go to www.sciencedirect.com and search for Cancer Treatment Reviews to find out more. . .. Pre-operative chemo-radiotherapy improves 3-year survival in people with respectable oesophageal cancer, 30:1 Anastrozole is safer and may be more effective than tamoxifen in postmenopausal women with early-stage breast cancer 30:3 Clinical effectiveness of radiotherapy for breast cancer, 30:2 Switching to exemestane after 2–3 years of adjuvant tamoxifen prolongs disease-free survival, but not overall survival, in postmenopausal women surviving primary breast cancer, compared with continuous tamoxifen, 30:6 Bevacizumab in combination with irinotecan plus fluorouracil plus leucovorin chemotherapy prolongs survival but increases adverse events in people with metastatic colorectal cancer, 30:8 Vancomycin does not benefit persistently febrile neutropenic people with cancer, 30:1 Dose-dense treatment prolongs disease-free survival of women with node positive breast cancer, 29:5 Clinical effectiveness of radiotherapy for Hodgkin’s lymphoma: a summary, 30:2
doi:10.1016/S0305-7372(05)00071-X
www.elsevierhealth.com/journals/ctrv
ANNOUNCEMENT
Most Popular Evidence-based Oncology Articles in 2004! The articles below were the most electronically downloaded Evidence-based Oncology articles last year in this journal. To find out what your peers are reading, go to www.sciencedirect.com and search for Cancer Treatment Reviews to find out more. . .. Pre-operative chemo-radiotherapy improves 3-year survival in people with respectable oesophageal cancer, 30:1 Anastrozole is safer and may be more effective than tamoxifen in postmenopausal women with early-stage breast cancer 30:3 Clinical effectiveness of radiotherapy for breast cancer, 30:2 Switching to exemestane after 2–3 years of adjuvant tamoxifen prolongs disease-free survival, but not overall survival, in postmenopausal women surviving primary breast cancer, compared with continuous tamoxifen, 30:6 Bevacizumab in combination with irinotecan plus fluorouracil plus leucovorin chemotherapy prolongs survival but increases adverse events in people with metastatic colorectal cancer, 30:8 Vancomycin does not benefit persistently febrile neutropenic people with cancer, 30:1 Dose-dense treatment prolongs disease-free survival of women with node positive breast cancer, 29:5 Clinical effectiveness of radiotherapy for Hodgkin’s lymphoma: a summary, 30:2
doi:10.1016/S0305-7372(05)00071-X